DEFA14A: Lifeway Foods: ISS Backs Management in Proxy Fight

Lifeway Foods announced that Institutional Shareholder Services (ISS) recommended shareholders reject the ongoing dissident-led consent solicitation.

Summary

• Lifeway Foods announced that Institutional Shareholder Services Inc. (ISS) recommended shareholders DO NOT VOTE in connection with the ongoing dissident-led consent solicitation.
• ISS concluded that the dissident group, led by Ludmila and Edward Smolyansky, has not presented a compelling case for change.
• ISS advised shareholders to DO NOT VOTE on all proposals put forth by the dissident group.
• CEO and Chair Julie Smolyansky stated that the consent solicitation is unwarranted, disruptive, and not in the best interest of Lifeway shareholders.

Sentiment

Score: 8

Explanation: The filing indicates strong support from ISS for Lifeway's current management against a dissident campaign, citing positive financial performance and share price outperformance relative to peers. This significantly strengthens the current board's position and reduces immediate governance uncertainty.

Positives

• Institutional Shareholder Services (ISS) recommended against the dissident campaign, supporting current management.
• Lifeway's financial performance has been directionally positive.
• Share price rallied over the preceding year on multiple positive earnings announcements.
• Total shareholder return significantly outperformed peers in the Russell 3000 Food Producers Index.
• ISS noted that the dissident group's critiques lacked adequate context and failed to establish how developments impacted shareholder returns.
• The dissident group has not presented a clear plan for governance or operational improvement.
• ISS highlighted that dissident nominees previously contributed to governance concerns during their past tenures at the Company.
• The Lifeway Board and management team remain focused on maximizing shareholder value and driving additional value.

Negatives

• An ongoing dissident-led consent solicitation by Ludmila and Edward Smolyansky and their aligned group is challenging current management.
• Management views the consent solicitation as unwarranted and disruptive.

Risks

• Shareholder activism and potential disruption from the ongoing dissident-led consent solicitation.
• Governance concerns associated with individuals proposed by the dissident group, who previously had tenures at the company.

Future Outlook

Management remains focused on maximizing shareholder value and will continue to pursue all opportunities to drive additional value. Shareholders are encouraged to follow ISS's guidance and take no action on the consent solicitation.

Management Comments

• "We appreciate ISSs thorough review and are pleased that their recommendation supports our belief that this consent solicitation is unwarranted, disruptive and not in the best interest of Lifeway shareholders." Julie Smolyansky, CEO and Chair of Lifeway Foods.
• "The Lifeway Board and management team remain focused on maximizing shareholder value and will continue to pursue all opportunities to drive additional value." Julie Smolyansky, CEO and Chair of Lifeway Foods.
• "We encourage shareholders to follow ISSs guidance and take no action on the consent solicitation." Julie Smolyansky, CEO and Chair of Lifeway Foods.

Industry Context

Lifeway Foods operates as a leading U.S. supplier of kefir and fermented probiotic products within the broader food producers industry. The company's outperformance against the Russell 3000 Food Producers Index suggests strong market positioning. The ongoing proxy fight, while a challenge, is a common aspect of corporate governance in publicly traded companies, particularly when dissidents perceive opportunities for change or value creation.

Comparison to Industry Standards

• Lifeway's total shareholder return significantly outperformed peers in the Russell 3000 Food Producers Index.

Stakeholder Impact

• Shareholders are directly impacted by the ISS recommendation, which advises them not to vote for the dissident proposals, influencing the outcome of the proxy contest and future board composition.
• Current management and the Board are strengthened by the ISS endorsement, supporting their ongoing strategic direction.
• Employees, customers, suppliers, and creditors are indirectly impacted by the increased stability and clarity in corporate governance resulting from the ISS recommendation.

Next Steps

• The Company intends to file a proxy statement on Schedule 14A and an accompanying BLUE proxy card for the 2025 annual meeting of shareholders.
• Shareholders are strongly encouraged to read the Company's definitive proxy statement and other relevant documents filed with the SEC.
• The Company may file a consent revocation statement.
• Management will continue to pursue all opportunities to drive additional value.
• Shareholders are encouraged to follow ISS's guidance and take no action on the consent solicitation.

Key Dates

Recommendation

ISS's recommendation to reject the dissident campaign is a significant positive for current management, reinforcing their position and validating their strategy given the company's strong financial performance and share price outperformance. However, the existence of an active dissident campaign, even if currently rebuffed by ISS, indicates ongoing internal governance challenges or shareholder dissatisfaction that could persist. Investors should hold to monitor the resolution of the proxy contest and ensure continued execution of the current strategy without significant disruption.

Keywords

Lifeway Foods, LWAY, Kefir, Probiotic, Fermented Products, SEC Filing, Proxy Fight, Shareholder Activism, ISS, Corporate Governance, Food Producers